Here is how Healthcare Services (HCSG) and Ralliant (RAL) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is how Healthcare Services (HCSG) and Ralliant (RAL) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is how Healthcare Services (HCSG) and Remitly Global, Inc. (RELY) have performed compared to their sector so far this year.
The average of price targets set by Wall Street analysts indicates a potential upside of 26% in Healthcare Services (HCSG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
HCSG, ELMD, UMBF, SHEL and MTSI passed an efficiency screen based on turnover ratios, asset use and operating margin strength.
HCSG, NUE, NEXA, LQDA and NKSH have been added to the Zacks Rank #1 (Strong Buy) List on May 13th, 2026.
NEXA, SHBI and HCSG made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 13th, 2026.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is how Healthcare Services (HCSG) and Remitly Global, Inc. (RELY) have performed compared to their sector so far this year.
Healthcare Services Group, Inc. (HCSG) is upgraded to BUY following three consecutive quarters of strong earnings beats and robust technical momentum. HCSG's revenue growth exceeds 6% year-over-year, with EBIT growth over 17%, supported by stable client relationships and effective management of Genesis bankruptcy risks. Cash flow from operations remains strong at $23.4 million in Q1, with $214.6 million in cash and marketable securities and an undrawn $300 million credit facility.